Ethicon Inc News Today

Dublin, May 20, 2024 (GLOBE NEWSWIRE) -- The

KKR to acquire Healthium Medtech for Rs 7000 crore from Apax Partners. Novo Holdings, Mankind Pharma, and ChrysCapital competed in the bidding. Anish Bafna will continue to lead Healthium under KKR ownership.

For the first time in nearly 15 years, the U.S. Patent and Trademark Office (USPTO) has issued "Updated Guidance for Making a Proper Determination of Obviousness" under the U.S.

For the first time in nearly 15 years, the U.S. Patent and Trademark Office (USPTO) has issued “Updated Guidance for Making a Proper Determination of Obviousness” under the U.S. Supreme...

The issue of the state of mind or intent of a party can play out a number of ways based on the nature of the case. In the criminal context, proof of…

The demand for advanced wound dressing is increasing owing to technological advancements, the increasing number of surgical procedures, and the rising...

KKR, Carlyle, EQT, Hillhouse, and TA Associates are competing to acquire Healthium Medtech, the largest homegrown surgical sutures and surgical needles manufacturer in India. Apax Partners currently owns 99.8% of Healthium. The company has a significant international presence and moderate client concentration risk.

BURLINGAME, Calif., Feb. 19, 2024 /PRNewswire/ — Coherent Market Insights published a report, titled, Global Skin Excision Market, By Type (Electrosurgical Excision Devices, Laser Excision Devices, Blades and Scalpels, curettes and gouges, and Others), By Application (Skin Cancer Excision, Lesion Removal, Wound Debridement, Acne Scar Removal, and Others), By Procedure Type (Brachioplasty, Mastopexy, Rhytidectomy, Panniculectomy, Thigh […]

Robotic Lung Biopsy MarketIt is anticipated that the value of the global robotic lung biopsy market sales will rise from US$ 408.0 million in 2023 to US$ 1,023.05 million in 2033. The need for robotic lung biopsies is expected to rise at a 9.6% CAGR over the next ten years, from 2023 to 2033.The Robotic Lung Biopsy...

The development and adoption of advanced hemostatic agents and devices have been critical in propelling the market forward. Innovations in biotechnology...